El Hajj H, Demey E, Poncet J, et al. The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling [J]. Proteomics, 2006, 6(21):5773-5784.
[8]
Weilhammer DR, Rasley A. Genetic approaches for understanding virulence in Toxoplasma gondii [J]. Brief Funct Genomics,2011, 10(6):365-373.
[9]
Reese ML, Zeiner GM, Saeij JP, et al. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence [J]. Proc Natl Acad Sci U S A, 2011, 108(23):9625-9630.
[10]
Behnke MS, Fentress SJ, Mashayekhi M, et al. The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18 [J]. PLoS Pathog, 2012, 8(11):e1002992.
Zheng B, Lu S, Tong Q,et al. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice [J]. Vaccine, 2013, 31(41):4578-4584.
